People Background Check
Find People:

Li Li Liu, Age 544739 Hylan Blvd, Staten Island, NY 10312

Get Report
Known as:
Li L Liu Lili L Liu Li Liu Li Li L L Tang Li L Tang Li Liliu Li W Wang Lillian Li Darryl Ballesteros Habib Khaliqi Liliu Li
Related to:
Yali Liu 55

Li Liu Phones & Addresses

4739 Hylan Blvd, Staten Island, NY 10312

623 52Nd St, Brooklyn, NY 11220

Flushing, NY

Hayward, CA

6412 16Th Ave, Brooklyn, NY 11204 (718) 236-4025

Mentions for Li Li Liu

Career records & work history

Real Estate Brokers

Li Liu Photo 1

Licensed Real Estate Salesperson

Specialties:
Buyer's Agent, Listing Agent
Work:
Robert DeFalco Realty, Inc.
655 Rossville Avenue, Staten Island, NY 10309
(718) 605-9300 (Office), (718) 877-0885 (Cell), (718) 605-9400 (Fax)
Links:
Site
Li Liu Photo 2

Li Liu, Staten Island NY - Agent

Work:
Robert DeFalco Realty, Inc
Staten Island, NY
(718) 877-0885 (Phone)
License #10391200787
Li Liu Photo 3

Li (Lily) Liu, Staten Island NY - Agent

Specialties:
Short sales
Residential sales
Luxury homes
First time home buyers
Relocation
Work:
Casandra Properties Inc
Staten Island, NY
(718) 877-0885 (Phone)
License #40LI1029092
Client type:
Home Sellers
Renters
Property type:
Single Family Home
Multi-family
Residential Rental
Li Liu Photo 4

Li Liu

Specialties:
Buyer's Agent, Listing Agent
Work:
DEFALCO REALTY
1678 Hylan Blvd, Staten Island, NY 10305
(718) 877-0885 (Office)

Medicine Doctors

Li M. Liu

Specialties:
Hematology/Oncology, Internal Medicine
Work:
Lebanon VA Medical Center Surgical Clinic
1700 S Lincoln Ave, Lebanon, PA 17042
(717) 272-6621 (phone) (717) 228-6118 (fax)
Education:
Medical School
Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71)
Graduated: 1982
Procedures:
Bone Marrow Biopsy, Chemotherapy
Conditions:
Anemia, Iron Deficiency Anemia, Non-Hodgkin's Lymphoma, Breast Neoplasm, Malignant, Hemolytic Anemia, Hodgkin's Lymphoma, Leukemia, Malignant Neoplasm of Female Breast, Multiple Myeloma
Languages:
English
Description:
Dr. Liu graduated from the Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) in 1982. He works in Lebanon, PA and specializes in Hematology/Oncology and Internal Medicine. Dr. Liu is affiliated with Lebanon VA Medical Center.

Li Liu

Specialties:
Radiation Oncology
Work:
Fresno Cancer Center
7887 N Cedar Ave, Fresno, CA 93720
(559) 437-1000 (phone) (559) 437-3870 (fax)
Education:
Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1987
Languages:
English, Spanish
Description:
Dr. Liu graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1987. He works in Fresno, CA and specializes in Radiation Oncology.

Li Liu

Specialties:
Internal Medicine
Work:
Garfield Health Center
210 N Garfield Ave STE 203, Monterey Park, CA 91754
(626) 307-7397 (phone) (626) 307-1807 (fax)
Education:
Medical School
Hunan Med Univ, Changsha City, Hunan, China
Graduated: 1985
Languages:
Chinese, English, Spanish, Vietnamese
Description:
Dr. Liu graduated from the Hunan Med Univ, Changsha City, Hunan, China in 1985. She works in Monterey Park, CA and specializes in Internal Medicine. Dr. Liu is affiliated with Garfield Medical Center and Pacific Alliance Medical Center.
Li Liu Photo 5

Li Liu

License Records

Li Liu

Licenses:
License #: 27485 - Active
Issued Date: Apr 26, 2010
Expiration Date: Jun 30, 2017
Type: Certified Public Accountant

Li Liu

Licenses:
License #: 06971 - Active
Category: Accountants
Issued Date: Oct 1, 2014
Expiration Date: Jun 30, 2018
Type: Certified Public Accountant

Li Liu

Licenses:
License #: 06971 - Active
Category: Accountants
Issued Date: Oct 1, 2014
Expiration Date: Jun 30, 2018
Type: Certified Public Accountant

Li Min Liu

Licenses:
License #: MT036825T - Expired
Category: Medicine
Type: Graduate Medical Trainee

Li Liu resumes & CV records

Resumes

Li Liu Photo 45

Li Liu

Work:
Michigan State University 2013 to Dec 2013 Melody Music School - New York, NY Jan 2011 to Jan 2013
piano teacher State University Oct 2010 to Apr 2011 Amadeus Music School - New York, NY Aug 2008 to Aug 2010
piano teacher Usher, Manhattan School of Music - New York, NY Sep 2008 to May 2010 Manhattan School of Music - New York, NY Apr 2009 to Apr 2009
Century Pianist Concert Showcase Tianjin Conservatory of Music Sep 2006 to May 2008
President of Student Union Jiangjie Music School Dec 2004 to May 2008
piano teacher Tianjin Conservatory Sep 2006 to Apr 2008
Chief Editor of School magazine Tianjin Conservatory of Music Sep 2005 to Jun 2007
Vice President of Psychology Association
Education:
Manhattan School of Music 2010
M. M. in piano Tianjin Conservatory of Music 2008
B. M. in piano Michigan State University
D.M.A. in piano
Li Liu Photo 46

Li Liu - Newark, NJ

Work:
Cellular Therapy Lab Apr 2010 to Present
Supervisor Cellular Therapy Lab - New York, NY Apr 2005 to Apr 2010
Technologist
Education:
Rutgers University May 2005
M.S. in Biological Sciences China Agricultural University Jul 2000
B.S. in Biochemistry and Physiology
Skills:
Aseptic skills, Proficient at Microsoft office, Proficient at flow cytometry, Act5, LH500 hematology analyzer, excellent communication skills etc.
Li Liu Photo 47

Li Liu - Bridgewater, NJ

Work:
NUTRAMETRIX HEALTH CONSULTATION 2006 to 2000
General Manager and Owner SANOFI INC 2009 to 2012
Scientist / Project Manager SANOFI INC 2005 to 2009
Associate Scientist
Education:
Wuhan University - South Plainfield, NJ 2012
BE in Instrumental Analysis University of California - Riverside, CA
MS in Chemistry
Li Liu Photo 48

Li Liu - Cranbury, NJ

Work:
Merck Research Laboratories/Schering-Plough Corp - Kenilworth, NJ Jan 2006 to Dec 2011
Scientist 1 Five Prime Therapeutics, Inc - South San Francisco, CA Jun 2003 to Jan 2006
Research Associate III, IV Sangamo Biosciences, Inc - Richmond, CA Jul 2002 to Apr 2003
Research Associate II Oklahoma Medical Research Foundation - Oklahoma City, OK Aug 2001 to Jun 2002
Research Assistant/Associate Department of Pharmacology & Toxicology, Indiana University School of Medicine - Indianapolis, IN Sep 1997 to Dec 1998
Research Technician Beijing Institute of Pharmacology and Toxicology Aug 1996 to Jul 1997
Technician
Education:
Beijing Medical College of PLA Jan 1987
B.S. in Medical Laboratory Science
Skills:
Molecular Biology: DNA and RNA isolation, PCR/RT-PCR and Taqman (real-time PCR), molecular cloning and Gateway cloning, generation of protein expression constructs, DNA sequencing. Cell Biology: Cell culture (including mouse embryonic stem cell), transfection. Transient expression of foreign genes in mammalian cells. Generation and maintenance of stable cell lines. Cell-based assay. Biochemistry: Cell lysate preparation, protein immunoprecipitation, SDS-PAGE, Western blotting, ELISA, protein purification by affinity chromatography, Meso Scale Discovery immunoassays. Animal Skills: Mice handling, genotyping, bleeding by cardiac puncture, subcutaneous and tail vein, dissection, tail vein injection and perfusion, tumor animal models. Isolation, microinjection and transfer of mouse blastocysts. Bile duct injection and islet isolation. Computer Skills: Microsoft word, Excel, PowerPoint, DNA Star, FileMaker, Prism, MSD software for data analysis.

Publications & IP owners

Us Patents

Method For Screening Compounds For The Treatment Of Neoplasia

US Patent:
6569638, May 27, 2003
Filed:
Mar 3, 2000
Appl. No.:
09/517734
Inventors:
I. Bernard Weinstein - Englewood NJ
W. Joseph Thompson - Doylestown PA
Jae-Won Soh - Cliffside Park NJ
Li Liu - Ambler PA
Han Li - Yardley PA
Assignee:
Cell Pathways, Inc - Horsham PA
International Classification:
C12Q 148
US Classification:
435 15, 435 692, 435184
Abstract:
This invention provides a method to identify compounds potentially useful for the treatment and prevention of neoplasia in mammals. The phosphodiesterase inhibitory activity of a compound is determined along with its ability to elevate JNK kinase activity. Growth inhibitory and apoptosis inducing effects on cultured tumor cells are also determined. Compounds that exhibit phosphodiesterase inhibition, an ability to elevate JNK kinase activity, growth inhibition and apoptosis induction are desirable for the treatment of neoplasia.

Methods And Apparatus For Polarization Control

US Patent:
7154670, Dec 26, 2006
Filed:
Mar 10, 2004
Appl. No.:
10/796930
Inventors:
Hongbin Zhang - Marlboro NJ, US
Li Liu - Carneys Point NJ, US
R. Brian Jander - Freehold NJ, US
Alexei N. Pilipetskii - Colts Neck NJ, US
Assignee:
Tyco Telecommunications (US) Inc. - Morristown NJ
International Classification:
G02B 27/28
US Classification:
359501, 359497, 385 11
Abstract:
Methods and apparatus of performing polarization control for optical transmissions. The methods and apparatus enable polarization control devices to achieve a desired output state of polarization regardless of the input state of polarization. The desired state of polarization can be achieved by rotating waveplates in a polarization controller in a sequential fashion. Each waveplate may be continually adjusted or dithered so long as the feedback signal satisfies a feedback condition. Once the feedback signal exceeds the feedback condition, the next waveplate in the polarization controller is adjusted. This enables the methods and apparatus to rapidly adjust the state of polarization away from dead spots and minimize loss control problems.

Piperidin-4-Yl-Azetidine Diamides As Monoacylglycerol Lipase Inhibitors

US Patent:
8513423, Aug 20, 2013
Filed:
Oct 20, 2011
Appl. No.:
13/277702
Inventors:
Peter J. Connolly - New Providence NJ, US
Haiyan Bian - Princeton NJ, US
Xun Li - New Hope PA, US
Li Liu - Germantown MD, US
Mark J. Macielag - Gwynedd Valley PA, US
Mark E. McDonnell - Lansdale PA, US
Assignee:
Janssen Pharmaceutica, NV
International Classification:
C07D 401/00
A61K 31/00
US Classification:
546208, 51421018
Abstract:
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula (I) as follows:.

Azetidinyl Diamides As Monoacylglycerol Lipase Inhibitors

US Patent:
2013012, May 16, 2013
Filed:
Dec 18, 2012
Appl. No.:
13/718056
Inventors:
JANSSEN PHARMACEUTICA NV - New Brunswick NJ, US
Kristen Chevalier - Collegeville PA, US
Jose Clemente - Spring House PA, US
Pete Connolly - Spring House PA, US
Chris Flores - Spring House PA, US
Shu-Chen Lin - Doylestown PA, US
Li Liu - Doylestown PA, US
John Mabus - East Greenville PA, US
Mark Macielag - Spring House PA, US
Mark McDonnell - Lansdale PA, US
Philip Pitis - North Wales PA, US
Yue-Mei Zhang - Spring House PA, US
Sui-Po Zhang - Radnor PA, US
Bin Zhu - Spring House PA, US
Assignee:
JANSSEN PHARMACEUTICA NV - New Brunswick NJ
International Classification:
C07D 417/12
C07D 401/10
C07D 471/04
C07D 403/14
C07D 403/06
C07D 495/04
C07D 417/14
C07D 417/06
US Classification:
51421018, 544369, 544364, 544363, 544371, 544373, 544362
Abstract:
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows:wherein Y, Z, R, and s are defined herein.

Azetidinyl Diamides As Monoacylglycerol Lipase Inhibitors

US Patent:
2013013, May 30, 2013
Filed:
Jan 25, 2013
Appl. No.:
13/749846
Inventors:
Janssen Pharmaceutica, NV - New Brunswick NJ, US
Kristen Chevalier - Collegeville NJ, US
Jose Clemente - Spring House PA, US
Peter Connolly - Spring House PA, US
Christopher Flores - Spring House PA, US
Shu-Chen Lin - Doylestown PA, US
Li Liu - Germantown MD, US
John Mabus - East Greenville PA, US
Mark Macielag - Spring House PA, US
Mark McDonnell - Lansdale PA, US
Philip Pitis - North Wales PA, US
Yue-Mei Zhang - Belle Mead NJ, US
Sui-Po Zhang - Radnor PA, US
Bin Zhu - Spring House PA, US
Assignee:
Janssen Pharmaceutica, NV - New Brunswick NJ
International Classification:
C07D 417/14
C07D 403/14
C07D 409/14
C07D 403/04
C07D 401/14
US Classification:
51421018, 544359, 544364, 544369, 544379, 544363, 544372, 544 586, 544373
Abstract:
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows:wherein Y, Z, R, and s are defined herein.

Inhibitor Of Atr Kinase For Use In A Method Of Treating A Hyper-Proliferative Disease

US Patent:
2021040, Dec 30, 2021
Filed:
Feb 1, 2021
Appl. No.:
17/164336
Inventors:
- Leverkusen, DE
- Berlin, DE
Bernard HÄNDLER - Berlin, DE
Sven GOLFIER - Berlin, DE
Andreas SCHLICKER - Berlin, DE
Li LIU - East Hanover NJ, US
Assignee:
Bayer Aktiengesellschaft - Leverkusen
Bayer Pharma Aktiengesellschaft - Berlin
International Classification:
C12Q 1/6886
A61P 35/00
A61K 31/5377
Abstract:
The present invention covers 2-[(3R)-3-methylmorpholin-4-yl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridine (in the following called “Compound A”), an inhibitor of ATR kinase, for use in a method of treating a hyper-proliferative disease in a subject. Preferably the hyper-proliferative disease or the subject is characterized by one or more biomarker(s) selected fromThe present invention also covers a kit comprising Compound A together with means to detect one or more of the aforementioned biomarker(s) and a method for identifying a subject having a hyper-proliferative disease disposed to respond favorably to Compound A, wherein the method comprises the detection of one or more of the aforementioned biomarker(s). Further, the invention covers a method of determining whether a subject having a hyper-proliferative disease will respond to the treatment with Compound A, wherein the method comprises the detection of one or more of the aforementioned biomarker(s) in a sample of the subject.

Predictive Markers For Atr Kinase Inhibitors

US Patent:
2020037, Dec 3, 2020
Filed:
Dec 4, 2018
Appl. No.:
16/770462
Inventors:
- Leverkusen, DE
Gerhard SIEMEISTER - Berlin, DE
Li LIU - East Hanover NJ, US
Assignee:
Bayer Aktiengesellschaft - Leverkusen
International Classification:
A61K 31/5377
C12Q 1/6886
A61P 35/00
Abstract:
The present invention covers an ATR kinase inhibitor, particularly 2-[(3R)-3-methylmorpholin-4-yl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(H-pyrazol-5-yl)-1,7-naphthyridine (“Compound A”), for use in the treatment of a hyper-proliferative disease in a subject, wherein the hyper-proliferative disease or the subject is or has been characterized by one or more biomarker(s), wherein the biomarker(s) comprise(s) a) one or more functional mutations in one or more gene(s)/protein(s) selected from RBBP8, APOBEC3A, APOBEC3B, CLSPN, ERCC, HUS1, MAD2L2, PGBD5, POLD1, RAD1, TIMELESS and/or TIPIN; and/or b) the expression of a fusion gene encoding a fusion protein selected from EWSR-ERG, EWSR1-FLI1, SS18-SSX and/or SS18-SSX2 gene/protein.

An Inhibitor Of Atr Kinase For Use In A Method Of Treating A Hyper-Proliferative Disease

US Patent:
2020006, Feb 27, 2020
Filed:
Feb 22, 2018
Appl. No.:
16/488033
Inventors:
- Leverkusen, DE
- Berlin, DE
Bernard HÄNDLER - Berlin, DE
Sven GOLFIER - Berlin, DE
Andreas SCHLICKER - Berlin, DE
Li LIU - East Hanover NJ, US
Assignee:
Bayer Aktiengesellschaft - Leverkusen
Bayer Pharma Aktiengesellschaft - Berlin
International Classification:
C12Q 1/6886
A61K 31/5377
A61P 35/00
Abstract:
The present invention covers 2-[(3R)-3-methylmorpholin-4-yl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyra-zol-5-yl)-1,7-naphthyridine (in the following called “Compound A”), an inhibitor of ATR kinase, for use in a method of treating a hyper-proliferative disease in a subject. Preferably the hyper-proliferative disease or the subject is characterized by one or more biomarker(s) selected from a) one or more functional mutation(s) in one or more gene(s)/protein(s) selected from APC, ATG5, ARID1A, ATM, ATR, ATRIP, ATRX, BAP1, BARD1, BLM, BRAF, BRCA1, BRCA2, BRIP1, CCND1, CCNE1, CCNE2, CDC7, CDK12, CHEK1, CHEK2, DCLRE1A, DCLRE1B, DCLRE1C, DYRK1A, EGFR, ERBB2, ERBB3, ERCC2, ERCC3, ERCC4, ER-CC5, FAM175A, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FBXO18, FBXW7, FEN1, GEN1, HDAC2, H2AFX, HRAS, KRAS, LIG4, MDC1, MLH1, MLH3, MRE11A, MSH2, MSH3, MSH6, MYC, NBN, NRAS, PALB2, PARP1, PARP2, PARP3, PARP4, PCNA, PIK3CA, PMS2, POLA1, POLB, POLH, POLL, POLN, POLQ, PRKDC, PTEN, RAD9A, RAD17, RAD18, RAD50, RAD51, RAD52, RAD54B, RAD54L, RB1, REV3L, RPA1, RPA2, SLX4, TDP1, TDP2, TM-PRSS2, TMPRSS2-ERG, TOPBP1, TOP2A, TOP2B, TP53, TP53BP1, TRRAP, UBE2N, UIMC1, USP1, WDR48, WRN, XPA, XR-CC1 XRCC2, XRCC3, XRCC4 and/or XRCC6 gene/protein; and/or b) the activation of the ALT pathway; and/or c) microsatellite instability. The present invention also covers a kit comprising Compound A together with means to detect one or more of the afore-biomarker(s) and a method for identifying a subject having a hyper-proliferative disease disposed to respond favorably to Compound A, wherein the method comprises the detection of one or more of the aforementioned biomarker(s). Further, the invention covers a method of determining whether a subject having a hyper-proliferative disease will respond to the treatment with Compound A, wherein the method comprises the detection of one or more of the aforementioned biomarker(s) in a sample of the subject.

Isbn (Books And Publications)

The Chinese Neolithic: Trajectories To Early States

Author:
Li Liu
ISBN #:
0521811848

State Formation In Early China

Author:
Li Liu
ISBN #:
0715632248

Les Erreurs Des Etudiants Chinois Dans L'Apprentissage Du Francais

Author:
Li Liu
ISBN #:
2892191971

Possible Relatives

Cynthia S Liu  David Y Liu  Dean Liu  Da J Liu  Debbie Y Liu  Dan Liu  Li Jun  Li Y Meng  Li L Lee 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.